News Focus
News Focus
icon url

boi568

03/31/21 7:33 PM

#305422 RE: georgejjl #305420

Do you know how many sites were recruiting around Feb 11?
icon url

georgejjl

03/31/21 8:21 PM

#305428 RE: georgejjl #305420

Expect the Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled 48-week Safety and Efficacy Trial of ANAVEX2-73 for the Treatment of Early Alzheimer's Disease (AD) to complete recruitment by or before the end of April 2021.

Good luck and GOD bless,